Should We Stop Using Botulinum Neurotoxin Type A in Patients With Neurogenic Detrusor Overactivity After Development of Secondary Resistance?

Saved in:
Bibliographic Details
Published inEuropean urology Vol. 60; no. 4; pp. 872 - 873
Main Authors Pistolesi, Donatella, Giannarini, Gianluca, Stampacchia, Giulia, Selli, Cesare
Format Journal Article
LanguageEnglish
Published Switzerland Elsevier B.V 01.10.2011
Subjects
Adult
Botulinum Toxins - therapeutic use
Botulinum Toxins, Type A - therapeutic use
Drug Resistance
Female
Humans
Male
Middle Aged
Neuromuscular Agents - therapeutic use
Treatment Outcome
Urinary Bladder, Neurogenic - drug therapy
Urinary Bladder, Overactive - drug therapy
Urology
Withholding Treatment
Young Adult
Online AccessGet full text

Cover

More Information
ISSN:0302-2838
1873-7560
DOI:10.1016/j.eururo.2011.07.034